<DOC>
	<DOCNO>NCT03078322</DOCNO>
	<brief_summary>The study evaluate safety efficacy AV-101 .</brief_summary>
	<brief_title>AV-101 Adjunct Antidepressant Therapy Patients With Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Diagnosed MDD , single recurrent , currently experience MDE least 8 week duration . Has history inadequate response least 1 approve antidepressant include least 1 3 current depressive episode . Meet threshold total HAMD17 score &gt; 20 If female , status nonchildbearing potential use acceptable form birth control . Body mass index 18 40 kg/m2 . Other criterion may apply Current diagnosis Axis I disorder persistent depressive disorder , agoraphobia , generalize anxiety disorder , social anxiety disorder , panic disorder , posttraumatic stress disorder , attention deficit disorder , complicate grief , binge eat disorder , obsessive compulsive disorder mild severity , specify anxiety disorder , specific phobia unless one clinically unstable . ( Note : MDD must primary diagnosis ) . History bipolar disorder , schizophrenia schizoaffective disorder , history psychotic symptom current previous depressive episode . History anorexia nervosa , bulimia nervosa , specify feed eat disorder , within 5 year screen . Women pregnant breastfeed positive pregnancy test screen baseline . Currently take prohibit adjunct therapy . Such drug must wash least 4 week prior baseline . Current diagnosis moderate severe substance use ( include alcohol ) disorder ( abuse dependence , define DSM5 ) , exception nicotine dependence , screen within 6 month prior screen . In opinion investigator , subject significant risk suicidal behavior Has receive electroconvulsive therapy , repetitive transcranial magnetic stimulation current episode . Has receive vagus nerve stimulation time prior screening . Any current past history physical condition , investigator 's opinion might put subject risk interfere study result interpretation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>